A prospective, randomized, double-blinded, placebo controlled, phase III study to evaluate the efficacy and safety of apatinib plus best supportive care (BSC) compared to placebo plus BSC in patients with advanced or metastatic gastric cancer: The ANGEL study.

被引：5
|
作者：
Kang, Yoon-Koo
Boku, Narikazu
Kang, Won Ki
Yoon, Harry H.
Cascinu, Stefano
Al-Batran, Salah-Eddin
Houston, Scott
Park, Cheol Hee
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS4138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4138
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Placebo-controlled, double-blinded multi-center phase III trial of XELIRI/FOLFIRI plus simvastatin in metastatic colorectal cancer
    Lim, Sung Hee
    Kim, Tae Won
    Han, Sae-Won
    Kang, Hye Jin
    Hwang, In Gyu
    Lee, Ji Yun
    Lee, Min-Young
    Kim, Hae Su
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Joon Oh
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Ham, Jun Soo
    Byeon, Seonggyu
    Kim, Hee Kyung
    Kang, Won Ki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC)
    Kang, Y.
    Ohtsu, A.
    Van Cutsem, E.
    Rha, S. Y.
    Sawaki, A.
    Park, S.
    Lim, H.
    Wu, J.
    Langer, B.
    Shah, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [43] REGARD: A phase III, randomized, double-blind trial of ramucirumab and best supportive care (BSC) versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line p
    Fuchs, Charles S.
    Tomasek, Jiri
    Cho, Jae Yong
    Filip, Dumitru
    Passalacqua, Rodolfo
    Goswami, Chancal
    Safran, Howard
    Dos Santos, Lucas Vieira
    Aprile, Giuseppe
    Ferry, David
    Melichar, Bohuslav
    Tehfe, Moustapha
    Topuzov, Eldar
    Tabernero, Josep
    Raymond Zalcberg, John
    Chau, Ian
    Koshiji, Minori
    Hsu, Yanzhi
    Schwartz, Jonathan
    Ajani, Jaffer
    CANCER RESEARCH, 2013, 73 (08)
  • [44] Efficacy and safety of plecanatide in Chinese patients with functional constipation: A phase III randomized, double-blinded, placebo-controlled, multicenter trial
    Bai, Tao
    Xu, Zhiyue
    Jiang, Yueping
    Zhao, Hong
    Yan, Peng
    Dai, Ning
    Chen, Xi
    Huang, Kunming
    Cui, Jun
    Xu, Min
    Jia, Shujuan
    Zhang, Juan
    Liu, Side
    Li, Xiaoqing
    Ai, Yaowei
    Zhang, Mingxin
    Wu, Yongdong
    Zhou, Weizhen
    Zhao, Rong
    Wu, Jianjun
    Wang, Bangmao
    Xu, Baohong
    Ding, Xiangwu
    Fang, Xiangming
    Yang, Shaoqi
    Ma, Yingcai
    Zhou, Zhongyin
    Lin, Lin
    Chen, Huixin
    Zhang, Heng
    Zhu, Yin
    Jiang, Bo
    Zhang, Xiaolan
    Wang, Xiaoyan
    Zou, Duowu
    Ye, Bin
    Zhang, Ling
    Shi, Ruihua
    Zhen, Yanbo
    Wang, Junping
    Liu, Youli
    Liao, Aijun
    Hou, Xiaohua
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36
  • [45] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    De Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Oliver
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Jaime, Jesus Corral
    Melemed, Symantha
    John, William J.
    Chouaki, Nadia
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib plus best supportive care (BSC) compared with placebo plus BSC in metastatic colorectal cancer (mCRC): Results from the FRESCO-2 trial
    Stintzing, Sebastian
    Tabernero, Josep
    Satoh, Taroh
    Dasari, Arvind
    Lonardi, Sara
    Eng, Cathy
    Garcia-Carbonero, Rocio
    Elez, Elena
    Yoshino, Takayuki
    Sobrero, Alberto F.
    Yao, James C.
    Kasper, Stefan
    Arnold, Dirk
    Basic, Edin
    Granold, Matthias
    Petschulies, Marco
    Wu, Liwen
    Chen, Lucy F.
    Yang, Zhao
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib plus best supportive care (BSC) compared with placebo plus BSC in metastatic colorectal cancer (mCRC): Results from the FRESCO-2 trial
    Stintzing, Sebastian
    Tabernero, Josep
    Satoh, Taroh
    Dasari, Arvind
    Lonardi, Sara
    Eng, Cathy
    Garcia-Carbonero, Rocio
    Elez, Elena
    Yoshino, Takayuki
    Sobrero, Alberto F.
    Yao, James C.
    Kasper, Stefan
    Arnold, Dirk
    Basic, Edin
    Granold, Matthias
    Petschulies, Marco
    Wu, Liwen
    Chen, Lucy
    Yang, Zhao
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 116 - 116
  • [48] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)
    Laack, E.
    Reck, M.
    Schumann, C.
    Eschbach, C.
    Kimmich, M.
    Brandts, C.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Pujol, J.-L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A. H.
    Visseren-Grul, C. M.
    Leschinger, M., I
    Thomas, M.
    ONKOLOGIE, 2012, 35 : 36 - 37
  • [49] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852
  • [50] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403
12345